A congeneric series of four bis benzamidine inhibitors sharing a dianhydrosugar isosorbide scaffold in common has been studied by crystal structure analysis and enzyme kinetics with respect to their binding to trypsin and factor amp; 8197;Xa. Within the series, aromatic interactions are an important determinant for selectivity discrimination among both serine proteases. To study the selectivity determining features in detail, we used trypsin mutants in which the original binding site is gradually substituted to finally resemble the factor amp; 8197;Xa binding pocket. The influence of these mutations has been analyzed on the binding of the closely related inhibitors. We present the crystal structures of the inhibitor complexes obtained by co...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
An efficient protease therapeutic must be more resistant to naturally occurring inhibitors\ud compar...
Understanding enzymic binding affinity is of fundamental scientific importance as well as a prerequi...
AbstractCrystal structures of DX9065a and a related bisamidino-aryl inhibitor specific for the blood...
ABSTRACT: Novel aryl derivatives of benzamidine were synthesized and tested for their inhibitory pot...
ABSTRACT: Novel aryl derivatives of benzamidine were synthesized and tested for their inhibitory pot...
Enzyme-inhibitor interactions are crucial for normal functioning of many biological pathways. Point ...
A congeneric series of benzamidine-type ligands with a central proline moiety and a terminal cycloal...
AbstractBackground: Involved or implicated in a wide spectrum of diseases, trypsin-like serine prote...
Enzyme-inhibitor interactions are crucial for normal functioning of many biological pathways. Point ...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
An efficient protease therapeutic must be more resistant to naturally occurring inhibitors\ud compar...
Understanding enzymic binding affinity is of fundamental scientific importance as well as a prerequi...
AbstractCrystal structures of DX9065a and a related bisamidino-aryl inhibitor specific for the blood...
ABSTRACT: Novel aryl derivatives of benzamidine were synthesized and tested for their inhibitory pot...
ABSTRACT: Novel aryl derivatives of benzamidine were synthesized and tested for their inhibitory pot...
Enzyme-inhibitor interactions are crucial for normal functioning of many biological pathways. Point ...
A congeneric series of benzamidine-type ligands with a central proline moiety and a terminal cycloal...
AbstractBackground: Involved or implicated in a wide spectrum of diseases, trypsin-like serine prote...
Enzyme-inhibitor interactions are crucial for normal functioning of many biological pathways. Point ...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin...
An efficient protease therapeutic must be more resistant to naturally occurring inhibitors\ud compar...